Linked Life Data

20873786

Source:http://linkedlifedata.com/resource/pubmed/id/20873786

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9
pubmed:dateCreated
2010-9-29
pubmed:abstractText
The ability to apply nanomaterials as targeted delivery agents for drugs and other therapeutics holds promise for a wide variety of diseases, including many types of cancer. A nanodelivery vehicle must demonstrate in vivo efficacy, diminished or no toxicity, stability, improved pharmacokinetics, and controlled-release kinetics. In this issue, Lee et al. construct polymer nanobins that fulfill these requirements and demonstrate effective delivery of doxorubicin in vivo to breast cancer cells. This Perspective explores the outlook for these nanobins as well as other technologies in this field and the challenges that lie ahead.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
1936-086X
pubmed:author
pubmed:issnType
Electronic
pubmed:day
28
pubmed:volume
4
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
4967-70
pubmed:meshHeading
pubmed:year
2010
pubmed:articleTitle
Nanoparticulate alternatives for drug delivery.
pubmed:affiliation
Department of Materials Science and Engineering, The Pennsylvania State University, University Park, Pennsylvania 16802, USA. jha3@ems.psu.edu
pubmed:publicationType
Journal Article, Comment, Review, Research Support, Non-U.S. Gov't